Spectrophotometric Determination of Certain Benzimidazole Proton Pump Inhibitors
نویسندگان
چکیده
Spectrophotometric method for the determination of certain proton pump inhibitors belonging to the benzimidazole class of compounds has been developed. The method is based on the reaction of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole with iron (III) and subsequent reaction with ferricyanide under neutral condition which yields Prussian blue product with maximum absorption at 720-730 nm. The commonly encountered excipients and additives that often accompany pharmaceutical preparations did not interfere with the determination. The method was applied for the determination of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole in pharmaceutical preparations and no difference was found statistically. Thus, the spectrophotometric method can be applied as inexpensive, rapid, easy, accurate and precise method for the routine analysis of the five proton pump inhibitors in pharmaceutical preparations.
منابع مشابه
Review article: the clinical pharmacology of proton pump inhibitors.
Proton pump inhibitors inhibit the gastric H+/K+-ATPase via covalent binding to cysteine residues of the proton pump. All proton pump inhibitors must undergo acid accumulation in the parietal cell through protonation, followed by activation mediated by a second protonation at the active secretory canaliculus of the parietal cell. The relative ease with which these steps occur with different pro...
متن کاملNeocuproine and Bathocuproine as New Reagents for the Spectrophotometric Determination of Certain Proton Pump Inhibitors
Simple, sensitive and selective spectrophotometric methods were developed for the determination of five antiulcer drugs namely, omeprazole (OMZ), lansoprazole (LNZ), pantoprazole (PNZ), rabeprazole (RBZ) and esomeprazole (EMZ) using neocuproine or bathocuproine as reagents. The reaction is based on the reduction of copper(II) to copper(I) by OMZ, LNZ, PNZ, RBZ and EMZ which subsequently reacts ...
متن کاملDevelopment of a New Rp-uplc Method for the Determination of Rabeprazole Sodium in Pharmaceutical Formulation and Application in Dissolution Studies
Rabeprazole sodium is a proton pump inhibitor with actions and uses similar to omeprazole. It is given orally as enteric-coated rabeprazole tablets and normally taken in the morning. For the treatment of severe ulcerative gastrooesophageal reflux desease, the usual dose is 20 mg once daily for 4 to 8 weeks. In the USA, a further 8-week course is permitted for the healing of erosive oeophagitis ...
متن کاملInhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
The effect of activated lansoprazole (AG 2000), a novel benzimidazole proton pump inhibitor, against hypha formation of Candida albicans was examined in hypha-forming medium pH 7 (HFM7) after 20 h. AG 2000, at 50-800 microM, did not inhibit germ tube formation. However, it inhibited elongation of germ tubes to form hyphae and favored conversion of germ tubes to resume yeast growth at concentrat...
متن کاملThe therapeutic journey of benzimidazoles: a review.
Presence of benzimidazole nucleus in numerous categories of therapeutic agents such as antimicrobials, antivirals, antiparasites, anticancer, anti-inflammatory, antioxidants, proton pump inhibitors, antihypertensives, anticoagulants, immunomodulators, hormone modulators, CNS stimulants as well as depressants, lipid level modulators, antidiabetics, etc. has made it an indispensable anchor for de...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 70 شماره
صفحات -
تاریخ انتشار 2008